There are many proteins of therapeutic interest that are inaccessible because they are not expressed by a cell, are not soluble when expressed, cannot be isolated or are modified by the cellular expression host in an undesirable way. Sutro has proven successfully that it can use its biochemical protein synthesis platform to rapidly explore the expression and folding of these inaccessible proteins.